Roivant Sciences Stock Analysis
ROIV Stock | USD 10.36 0.03 0.29% |
Roivant Sciences is undervalued with Real Value of 12.54 and Target Price of 16.22. The main objective of Roivant Sciences stock analysis is to determine its intrinsic value, which is an estimate of what Roivant Sciences is worth, separate from its market price. There are two main types of Roivant Sciences' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Roivant Sciences' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Roivant Sciences' stock to identify patterns and trends that may indicate its future price movements.
The Roivant Sciences stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Roivant Sciences is usually not traded on Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day. Roivant Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Roivant Sciences' ongoing operational relationships across important fundamental and technical indicators.
Roivant |
Roivant Stock Analysis Notes
About 21.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.45. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Roivant Sciences recorded earning per share (EPS) of 5.23. The entity had not issued any dividends in recent years. Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company was founded in 2014 and is based in London, the United Kingdom. Roivant Sciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 863 people. To find out more about Roivant Sciences contact Matthew Gline at 44 20 7400 3347 or learn more at https://roivant.com.Roivant Sciences Quarterly Total Revenue |
|
Roivant Sciences Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Roivant Sciences' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Roivant Sciences or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Roivant Sciences generated a negative expected return over the last 90 days | |
The company reported the previous year's revenue of 61.28 M. Net Loss for the year was (1.12 B) with loss before overhead, payroll, taxes, and interest of (477.06 M). | |
Roivant Sciences currently holds about 1.94 B in cash with (843.39 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.76. | |
Roivant Sciences has a strong financial position based on the latest SEC filings | |
Roughly 67.0% of the company shares are owned by institutional investors | |
Latest headline from finance.yahoo.com: Vivek Ramaswamy Breathes New Life Into Beaten Down BuzzFeed Stock Whats Going On |
Roivant Sciences Upcoming and Recent Events
Earnings reports are used by Roivant Sciences to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Roivant Sciences previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
12th of February 2024 Upcoming Quarterly Report | View | |
26th of June 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
26th of June 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of March 2023 Last Financial Announcement | View |
Roivant Largest EPS Surprises
Earnings surprises can significantly impact Roivant Sciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2022-06-28 | 2022-03-31 | -0.32 | -0.27 | 0.05 | 15 | ||
2023-08-14 | 2023-06-30 | -0.3 | -0.38 | -0.08 | 26 | ||
2023-11-13 | 2023-09-30 | -0.31 | -0.4 | -0.09 | 29 |
Roivant Sciences Environmental, Social, and Governance (ESG) Scores
Roivant Sciences' ESG score is a quantitative measure that evaluates Roivant Sciences' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Roivant Sciences' operations that may have significant financial implications and affect Roivant Sciences' stock price as well as guide investors towards more socially responsible investments.
Roivant Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Roivant Sciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Roivant Sciences backward and forwards among themselves. Roivant Sciences' institutional investor refers to the entity that pools money to purchase Roivant Sciences' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Baker Bros Advisors Lp | 2023-12-31 | 7.6 M | Farallon Capital Management, L.l.c. | 2023-12-31 | 7.3 M | Vanguard Group Inc | 2023-12-31 | 7.1 M | Woodline Partners Lp | 2023-12-31 | 6.2 M | Geode Capital Management, Llc | 2023-12-31 | 5.5 M | Adage Capital Partners Gp Llc | 2023-12-31 | 5.3 M | Anchorage Advisors, Llc | 2023-12-31 | 4.8 M | Venbio Select Advisor Llc | 2023-12-31 | 4.7 M | Octagon Capital Advisors Lp | 2023-09-30 | 4.4 M | Qvt Financial Lp | 2023-12-31 | 112.5 M | Sb Investment Advisers (uk) Ltd | 2023-12-31 | 73 M |
Roivant Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 8.65 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Roivant Sciences's market, we take the total number of its shares issued and multiply it by Roivant Sciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Roivant Profitablity
Roivant Sciences' profitability indicators refer to fundamental financial ratios that showcase Roivant Sciences' ability to generate income relative to its revenue or operating costs. If, let's say, Roivant Sciences is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Roivant Sciences' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Roivant Sciences' profitability requires more research than a typical breakdown of Roivant Sciences' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 36.24 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of (7.74) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $7.74. Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.61 | 0.64 | |
Return On Capital Employed | 0.61 | 0.64 | |
Return On Assets | 0.60 | 0.63 | |
Return On Equity | 0.73 | 0.77 |
Management Efficiency
Roivant Sciences has return on total asset (ROA) of (0.1377) % which means that it has lost $0.1377 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 1.058 %, meaning that it created $1.058 on every $100 dollars invested by stockholders. Roivant Sciences' management efficiency ratios could be used to measure how well Roivant Sciences manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to climb to 0.64 in 2024. Return On Capital Employed is likely to climb to 0.64 in 2024. At this time, Roivant Sciences' Net Tangible Assets are fairly stable compared to the past year. Total Current Assets is likely to climb to about 2.1 B in 2024, whereas Non Current Assets Total are likely to drop slightly above 416.3 M in 2024.Last Reported | Projected for Next Year | ||
Book Value Per Share | 7.62 | 6.19 | |
Net Current Asset Value | 0.00 | 0.00 | |
Tangible Asset Value | 0.00 | 0.00 | |
Tangible Book Value Per Share | 8.06 | 6.70 | |
Enterprise Value Over EBITDA | 0.50 | 0.48 | |
Price Book Value Ratio | 1.37 | 2.15 | |
Enterprise Value Multiple | 0.50 | 0.48 | |
Price Fair Value | 1.37 | 2.15 | |
Enterprise Value | 2.1 B | 1.3 B |
The analysis of Roivant Sciences' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Roivant Sciences' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Roivant Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta 1.296 |
Technical Drivers
As of the 31st of May, Roivant Sciences holds the Variance of 4.84, coefficient of variation of (7,863), and Risk Adjusted Performance of (0.0005). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Roivant Sciences, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to collect and analyze data for thirteen technical drivers for Roivant Sciences, which can be compared to its competitors. Please check Roivant Sciences variance and skewness to decide if Roivant Sciences is priced some-what accurately, providing market reflects its current price of 10.36 per share. Given that Roivant Sciences has information ratio of (0.02), we recommend you to check out Roivant Sciences's recent market performance to make sure the company can sustain itself at a future point.Roivant Sciences Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Roivant Sciences middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Roivant Sciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Roivant Sciences Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Roivant Sciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Roivant Sciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Roivant Sciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Roivant Sciences Predictive Daily Indicators
Roivant Sciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Roivant Sciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Accumulation Distribution | 281976.0 | |||
Daily Balance Of Power | (0.09) | |||
Rate Of Daily Change | 1.0 | |||
Day Median Price | 10.38 | |||
Day Typical Price | 10.37 | |||
Price Action Indicator | (0.03) | |||
Period Momentum Indicator | (0.03) |
Roivant Sciences Corporate Filings
8K | 30th of May 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 22nd of May 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 30th of April 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 26th of April 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 24th of April 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 23rd of April 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F3 | 12th of April 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
8K | 2nd of April 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Roivant Sciences Forecast Models
Roivant Sciences' time-series forecasting models are one of many Roivant Sciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Roivant Sciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Roivant Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Roivant Sciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Roivant shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Roivant Sciences. By using and applying Roivant Stock analysis, traders can create a robust methodology for identifying Roivant entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | 56.67 | 59.50 | |
Operating Profit Margin | 56.52 | 59.34 | |
Net Profit Margin | 57.94 | 60.84 | |
Gross Profit Margin | 0.79 | 0.92 |
Current Roivant Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Roivant analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Roivant analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
16.22 | Strong Buy | 11 | Odds |
Most Roivant analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Roivant stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Roivant Sciences, talking to its executives and customers, or listening to Roivant conference calls.
Roivant Stock Analysis Indicators
Roivant Sciences stock analysis indicators help investors evaluate how Roivant Sciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Roivant Sciences shares will generate the highest return on investment. By understating and applying Roivant Sciences stock analysis, traders can identify Roivant Sciences position entry and exit signals to maximize returns.
Begin Period Cash Flow | 2.1 B | |
Long Term Debt | 375.5 M | |
Common Stock Shares Outstanding | 712.8 M | |
Total Stockholder Equity | 1.6 B | |
Total Cashflows From Investing Activities | -44.3 M | |
Tax Provision | 5.2 M | |
Property Plant And Equipment Net | 92.3 M | |
Cash And Short Term Investments | 1.7 B | |
Cash | 1.7 B | |
Accounts Payable | 37.8 M | |
Net Debt | -1.2 B | |
50 Day M A | 10.966 | |
Total Current Liabilities | 272.4 M | |
Other Operating Expenses | 1.1 B | |
Non Current Assets Total | 591 M | |
Non Currrent Assets Other | 49.5 M | |
Stock Based Compensation | 217.8 M |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Roivant Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Roivant Stock please use our How to Invest in Roivant Sciences guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Complementary Tools for Roivant Stock analysis
When running Roivant Sciences' price analysis, check to measure Roivant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roivant Sciences is operating at the current time. Most of Roivant Sciences' value examination focuses on studying past and present price action to predict the probability of Roivant Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roivant Sciences' price. Additionally, you may evaluate how the addition of Roivant Sciences to your portfolios can decrease your overall portfolio volatility.
Stocks Directory Find actively traded stocks across global markets | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |
Is Roivant Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Roivant Sciences. If investors know Roivant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Roivant Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 5.23 | Revenue Per Share 0.16 | Quarterly Revenue Growth 1.178 | Return On Assets (0.14) | Return On Equity 1.058 |
The market value of Roivant Sciences is measured differently than its book value, which is the value of Roivant that is recorded on the company's balance sheet. Investors also form their own opinion of Roivant Sciences' value that differs from its market value or its book value, called intrinsic value, which is Roivant Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Roivant Sciences' market value can be influenced by many factors that don't directly affect Roivant Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Roivant Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Roivant Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Roivant Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.